Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Galectin Therapeutics Inc (GALT)  
$3.08 0.05 (1.65%) as of 4:30 Mon 5/13


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 57,080,000
Market Cap: 175.81(M)
Last Volume: 97,895 Avg Vol: 97,624
52 Week Range: $1.32 - $4.2
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drugs - Generic

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    : 5.4
Insider 6 Months    : 6.1
Insider 3/6 Months : 11.5
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Galectin Therapeutics is a clinical stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease, cancer and selected other diseases. Co.'s main galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis and in clinical studies to decrease portal hypertension and prevent its complication: the development of esophageal varices. GR-MD-02 has the potential to treat various diseases due to galectin-3's involvement in multiple main biological pathways such as fibrosis, immune cell function and immunity, cell differentiation, cell growth, and apoptosis (cell death).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,500 5,000 6,598 33,898
Total Buy Value $14,360 $15,253 $18,107 $61,191
Total People Bought 3 4 4 5
Total Buy Transactions 3 4 5 12
Total Shares Sold 25,000 25,000 25,000 45,000
Total Sell Value $76,500 $76,500 $76,500 $118,240
Total People Sold 1 1 1 2
Total Sell Transactions 2 2 2 4
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 517
  Page 16 of 21  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Traber Peter G President and CEO   •       •      –    2012-10-09 4 B $2.00 $5,000 D/D 2,500 507,500 2.81     -
   Traber Peter G President and CEO   •       •      –    2012-10-08 4 B $2.07 $10,350 D/D 5,000 505,000 2.81     -
   Greenberg Arthur Director   –       •      –    2012-07-18 4 B $1.84 $9,200 D/D 5,000 94,667 2.39     -
   Amelio Gilbert F Director   –       •      –    2012-06-20 4 B $2.10 $15,750 D/D 7,500 92,084 2.39     -
   Prelack Steven Director   –       •      –    2012-06-15 5 A $2.14 $5,136 D/D 2,400 2,400     -
   Martin Rod D Director   –       •      –    2012-05-25 4 B $2.44 $12,200 D/D 5,000 91,488 2.39     -
   Mcgauley Thomas Chief Financial Officer   •       –      –    2012-05-24 4 B $2.35 $23,500 D/D 10,000 10,000 2.74     -
   Mauldin John F Director   –       •      –    2012-04-25 4 B $3.08 $3,388 I/I 1,100 4,947 2.1     -
   Pressler Herman Paul Director   –       •      –    2012-04-25 4 B $3.10 $15,515 D/D 5,000 9,500 2.39     -
   Mauldin John F Director   –       •      –    2012-04-24 4 B $2.94 $11,310 I/I 3,847 3,847 2.1     -
   Greenberg Arthur Director   –       •      –    2012-04-17 4 B $2.84 $8,520 D/D 3,000 89,667 2.39     -
   Rubin Marc Director   –       •      –    2011-10-18 4 B $0.96 $19,200 D/D 20,000 20,000 2.39     -
   Czirr James C Executive Chairman   •       •       •   2011-09-30 4 A $1.00 $6,000 I/I 6,000 179,232     -
   Czirr James C Executive Chairman   •       •       •   2011-09-30 4 A $0.92 $190,186 I/I 206,724 9,069,422     -
   Czirr James C Executive Chairman   •       •       •   2011-09-30 4 OE $0.50 $1,205,000 I/I 2,410,000 8,862,698     -
   Martin Rod D Director   –       •       •   2011-09-30 4 A $0.92 $190,227 I/I 206,724 9,069,422     -
   Martin Rod D Director   –       •       •   2011-09-30 4 OE $0.50 $1,205,000 I/I 2,410,000 8,862,698     -
   10x Capital Management, Llc 10% Owner   –       –       •   2011-09-30 4 A $0.92 $190,227 I/I 206,724 9,069,422     -
   10x Capital Management, Llc 10% Owner   –       –       •   2011-09-30 4 OE $0.50 $1,205,000 I/I 2,410,000 8,862,698     -
   Czirr James C Executive Chairman   •       •       •   2011-07-12 4 GD $1.08 $34,560 D/D 32,000 4,065,268     -
   Martin Rod D Director   –       •       •   2011-06-30 4 OE $1.22 $4,379,800 I/I 3,590,000 6,452,698     -
   Martin Rod D Director   –       •       •   2011-06-30 4 A $1.22 $464,180 I/I 380,475 2,862,698     -
   10x Capital Management, Llc 10% Owner   –       –       •   2011-06-30 4 OE $1.22 $4,379,800 I/I 3,590,000 6,452,698     -
   10x Capital Management, Llc 10% Owner   –       –       •   2011-06-30 4 A $1.22 $464,180 I/I 380,475 2,862,698     -
   Czirr James C Executive Chairman   •       •       •   2011-06-30 4 OE $1.22 $4,379,800 I/I 3,590,000 6,452,698     -
  517 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 16 of 21
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us